miralax orange flavor

Generic: polyethylene glycol 3350

Labeler: bayer healthcare llc.
NDC Directory HUMAN OTC DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name miralax orange flavor
Generic Name polyethylene glycol 3350
Labeler bayer healthcare llc.
Dosage Form POWDER, FOR SOLUTION
Routes
ORAL
Active Ingredients

polyethylene glycol 3350 17 g/17g

Manufacturer
Bayer HealthCare LLC.

Identifiers & Regulatory

Product NDC 11523-0122
Product ID 11523-0122_4526ca58-f032-31ad-e063-6394a90a7bae
Product Type HUMAN OTC DRUG
Marketing Category ANDA
Application Number ANDA090685
Listing Expiration 2026-12-31
Marketing Start 2023-09-15

Pharmacologic Class

Established (EPC)
osmotic laxative [epc]
Mechanism of Action
osmotic activity [moa]
Physiologic Effect
stimulation large intestine fluid/electrolyte secretion [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 115230122
Hyphenated Format 11523-0122

Supplemental Identifiers

RxCUI
876193 876195
UPC
0041100600554
UNII
G2M7P15E5P
NUI
N0000010288 N0000175811 N0000009871

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name miralax orange flavor (source: ndc)
Generic Name polyethylene glycol 3350 (source: ndc)
Application Number ANDA090685 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 17 g/17g
source: ndc
Packaging
  • 238 g in 1 BOTTLE (11523-0122-1)
  • 119 g in 1 BOTTLE (11523-0122-2)
source: ndc

Packages (2)

Ingredients (1)

polyethylene glycol 3350 (17 g/17g)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "4526ca58-f032-31ad-e063-6394a90a7bae", "openfda": {"nui": ["N0000010288", "N0000175811", "N0000009871"], "upc": ["0041100600554"], "unii": ["G2M7P15E5P"], "rxcui": ["876193", "876195"], "spl_set_id": ["0a5b2121-928f-8f49-e063-6394a90a8aaf"], "pharm_class_pe": ["Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]"], "pharm_class_epc": ["Osmotic Laxative [EPC]"], "pharm_class_moa": ["Osmotic Activity [MoA]"], "manufacturer_name": ["Bayer HealthCare LLC."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "238 g in 1 BOTTLE (11523-0122-1)", "package_ndc": "11523-0122-1", "marketing_start_date": "20230915"}, {"sample": false, "description": "119 g in 1 BOTTLE (11523-0122-2)", "package_ndc": "11523-0122-2", "marketing_start_date": "20230915"}], "brand_name": "MiraLAX Orange Flavor", "product_id": "11523-0122_4526ca58-f032-31ad-e063-6394a90a7bae", "dosage_form": "POWDER, FOR SOLUTION", "pharm_class": ["Osmotic Activity [MoA]", "Osmotic Laxative [EPC]", "Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]"], "product_ndc": "11523-0122", "generic_name": "Polyethylene Glycol 3350", "labeler_name": "Bayer HealthCare LLC.", "product_type": "HUMAN OTC DRUG", "brand_name_base": "MiraLAX Orange Flavor", "active_ingredients": [{"name": "POLYETHYLENE GLYCOL 3350", "strength": "17 g/17g"}], "application_number": "ANDA090685", "marketing_category": "ANDA", "marketing_start_date": "20230915", "listing_expiration_date": "20261231"}